netFormulary
 Report : A-Z CDF items in Formulary 21/02/2020 11:44:38
[Back]
 
Section Status CDF Name
08.03.04.02 Formulary Cancer Drugs Fund Abiraterone Zytiga®
08.01.05 Formulary Cancer Drugs Fund Atezolizumab Tecentriq®
08.01.01 Formulary Cancer Drugs Fund Bendamustine 
08.01.05 Formulary Cancer Drugs Fund Bevacizumab Avastin®
08.01.05 Formulary Cancer Drugs Fund Bortezomib Velcade®
08.01.05 Formulary Cancer Drugs Fund Bosutinib Bosulif®
08.01.05 Formulary Cancer Drugs Fund Brentuximab vedotin Adcetris®
08.01.05 Formulary Cancer Drugs Fund Cabazitaxel Jevtana®
08.01.05 Formulary Cancer Drugs Fund Cabozantinib Cometriq®
08.01.05 Formulary Cancer Drugs Fund Cetuximab Erbitux®
08.01.03 Formulary Cancer Drugs Fund Clofarabine Evoltra®
08.01.05 Formulary Cancer Drugs Fund Crizotinib Xalkori®
08.01.05 Formulary Cancer Drugs Fund Dabrafenib Tafinlar®
08.01.05 Formulary Cancer Drugs Fund Dasatinib Sprycel®
08.01.02 Formulary Cancer Drugs Fund Daunorubicin 44mg / Cytarabine 100mg Vyxeos
08.01.02 Formulary Cancer Drugs Fund Doxorubicin Hydrochloride Caelyx®
08.01.05 Formulary Cancer Drugs Fund Eribulin Halaven®
08.01.05 Formulary Cancer Drugs Fund Idelalisib Zydelig®
08.02.04 Formulary Cancer Drugs Fund Lenalidomide  Revlimid®
08.01.03 Formulary Cancer Drugs Fund Nelarabine Atriance®
08.01.03 Formulary Cancer Drugs Fund Pemetrexed Alimta®
08.01.05 Formulary Cancer Drugs Fund Pertuzumab Perjeta®
08.02.04 Formulary Cancer Drugs Fund Pomalidomide Imnovid®
08.01.05 Formulary Cancer Drugs Fund Ponatinib Iclusig®
08.01.05 Formulary Cancer Drugs Fund Ruxolitinib Jakavi®
08.01.05 Formulary Cancer Drugs Fund Sunitinib 
08.01.05 Formulary Cancer Drugs Fund Temsirolimus Torisel®
08.01.05 Formulary Cancer Drugs Fund Venetoclax Venclyxto®
08.01.05 Formulary Cancer Drugs Fund Vismodegib Erivedge®
Chelsea and Westminster Hospital